What Global Oncology Needs: Mutual Learning and More Funding.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies.JCO global oncology · 2022
   Pooled it
2. Highlights fromEcancermedicalscience · 2022
   Article
3. Understanding the bricks to build better surgical oncology unit at Maputo Central Hospital: prevalent surgical cancers and residents knowledge.The Pan African medical journal · 2019
   Article
4. A hospital-based cancer registry in Luanda, Angola: theInfectious agents and cancer · 2019
   Article
5. Cancer in Santiago Island, Cape Verde: data from the Hospital Agostinho Neto Cancer Registry (2017-2018).Ecancermedicalscience · 2019
   Article

Corrections and comments

• Comment on
  Perspectives on Strengthening Cancer Research and Control in Latin America Through Partnerships and Diplomacy: Experience of the National Cancer Institute's Center for Global Health.2018

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as